Alan E. Einstein, D.O.’92
Alan E. Einstein, D.O.’92, has been appointed to the board of CURE Pharmaceutical, a leading disruptive drug delivery technology company researching cannabinoid molecules for various health care applications. He practices at EMC2Care in Alpharetta, GA, and has numerous areas of
Alan E. Einstein, D.O.’92 Read More


